Search by Drug Name or NDC
NDC 00023-9652-01 DURYSTA 10 ug/1 Details
DURYSTA 10 ug/1
DURYSTA is a INTRACAMERAL IMPLANT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is BIMATOPROST.
Product Information
NDC | 00023-9652 |
---|---|
Product ID | 0023-9652_ebbce360-a6dd-423b-98da-f6a16f6153e7 |
Associated GPIs | 86330015002320 |
GCN Sequence Number | 080813 |
GCN Sequence Number Description | bimatoprost IMPLANT 10 MCG INTRAOCULR |
HIC3 | Q6G |
HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
GCN | 47792 |
HICL Sequence Number | 022000 |
HICL Sequence Number Description | BIMATOPROST |
Brand/Generic | Brand |
Proprietary Name | DURYSTA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | bimatoprost |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | IMPLANT |
Route | INTRACAMERAL |
Active Ingredient Strength | 10 |
Active Ingredient Units | ug/1 |
Substance Name | BIMATOPROST |
Labeler Name | Allergan, Inc. |
Pharmaceutical Class | Prostaglandin Analog [EPC], Prostaglandins [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA211911 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00023-9652-01 (00023965201)
NDC Package Code | 0023-9652-01 |
---|---|
Billing NDC | 00023965201 |
Package | 1 IMPLANT in 1 POUCH (0023-9652-01) |
Marketing Start Date | 2020-03-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |